Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:
“Letters to editor is best part of any journal and most of the times gives some newer insights in the clinical trial analysis.
3 such excellent letters published in NEJM and reply by Authors about Keynote 522 trial.
Must read for all oncologist. Congratulations to Authors.”
